Seventy-six Americans were diagnosed with Powassan virus in 2025, marking the highest annual total on record for the rare, potentially fatal tick-borne illness. This figure represents a stark increase from the previous average of just seven to eight diagnoses each year, revealing a deepening public health crisis. The virus can progress from initial infection to severe neurological illness and death far faster than Lyme disease, often within minutes of a bite.
The Human Cost of Neglect
Experts warn that Powassan virus can spread to humans in as little as 15 minutes after an infected tick bites. Dr. Jorge P. Parada, a medical advisor at the National Pest Management Association in Chicago, emphasized its rapid transmission. He noted that Lyme disease typically requires a 36- to 48-hour attachment time for transmission, highlighting Powassan's immediate danger. Dr. Marc Siegel, senior medical analyst for Fox News, also confirmed the significantly faster transmission rate.
The virus carries an incubation period of one to four weeks before symptoms appear. Initial symptoms include fever, headache, vomiting, and weakness, though some infected individuals remain asymptomatic. The Centers for Disease Control and Prevention (CDC) reports that the virus can escalate to severe neurological complications, including encephalitis, which is brain inflammation, and meningitis, an inflammation of the spinal cord membranes. Patients in severe cases may experience confusion, loss of coordination, difficulty speaking, and seizures.
About 10% of Powassan cases involving severe neurological disease prove fatal. Many survivors endure long-term neurological issues, a permanent burden on their lives and livelihoods. Children, older adults, and immunocompromised people face the highest risk, though anyone can develop severe illness, underscoring the broad vulnerability across the population.
Capital's Disinterest in a Cure
Despite the escalating human cost, there are no specific medications or vaccines to treat or prevent Powassan virus. Clinical care remains limited to supportive therapy, such as intravenous fluids and respiratory support. This absence of targeted treatment reflects a systemic failure, where the market-driven pharmaceutical industry finds little profit in developing solutions for a disease deemed "rare," even as its incidence climbs.
Powassan virus is primarily transmitted through the bite of an infected woodchuck tick or deer tick. It is most prevalent from late spring through mid-fall, a period when tick populations peak and outdoor activity increases. This seasonal surge disproportionately affects those whose labor or living conditions expose them to outdoor environments, further entrenching health disparities.
Researchers first identified the virus near Powassan, Ontario, 68 years ago, following a 1958 case involving a young boy on a farm. Lincoln Byers, a 4-year-old living in Canada, died from an unexplained condition. Years later, a tick harboring the same virus was discovered on a dead squirrel, providing a tragic answer and pointing to a growing public health challenge that capital has largely ignored.